2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial. (September 2015) - Ducreux, M.; Bennouna, J.; Adenis, A.; Conroy, T.; Lievre, A.; Portales, F.; McGovern, D.; Li, L.; Romano, A.